The TyG index offers a more practical and cost-effective alternative to the classical homeostasis model assessment of insulin resistance (such as homeostatic model assessment of insulin resistance (HOMA-IR)), which requires additional measurement of fasting insulin levels, while maintaining accuracy comparable to the conventional method. This evidence concerns the gene INS and Insulin resistance.